Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor
- 1 January 2000
- journal article
- Published by Elsevier in Kidney International
- Vol. 57 (1), 33-40
- https://doi.org/10.1046/j.1523-1755.2000.00829.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- New insights into the molecular pathophysiology of polycystic kidney diseaseKidney International, 1999
- Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): Molecular genetics, clinical experience, and fetal morphologyAmerican Journal of Medical Genetics, 1998
- Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKDAmerican Journal of Physiology-Cell Physiology, 1995
- Biliary Epithelial Cells from Mice with Congenital Polycystic Kidney Disease Are Hyperresponsive to Epidermal Growth FactorPediatric Research, 1995
- Epidermal Growth Factor Precursor Is Present in a Variety of Human Renal Cyst FluidsJournal of Urology, 1995
- Epidermal growth factor receptor expression is abnormal in murine polycystic kidneyKidney International, 1995
- Evidence for a third genetic locus for autosomal dominant polycystic kidney diseaseGenomics, 1995
- Epidermal Growth Factor and Endothelin in Cyst Fluid From Autosomal Dominant Polycystic Kidney Disease Cases: Possible Evidence of Heterogeneity in CystogenesisAmerican Journal of Kidney Diseases, 1994
- In vitro formation and expansion of cysts derived from human renal cortex epithelial cellsKidney International, 1992
- Genetic Heterogeneity of Polycystic Kidney Disease in Europe1Published by S. Karger AG ,1991